α: An In Vitro and In Vivo Study2: An In Vitro and In Vivo Study(VIII) Collagen Substrata Enhance Endothelial Cell Retention Under Acute Shear Stress Flow via an α: An In Vitro and In Vivo Study2: An In Vitro and In Vivo Studyβ: An In Vitro and In Vivo Study1: An In Vitro and In Vivo Study Integrin–Dependent Mechanism: An In Vitro and In Vivo Study

    loading  Checking for direct PDF access through Ovid

Abstract

Background—

Essential to tissue-engineered vascular grafts is the formation of a functional endothelial monolayer capable of resisting the forces of blood flow. This study targeted α2(VIII) collagen, a major component of the subendothelial matrix, and examined the ability of and mechanisms by which endothelial cells attach to this collagen under static and dynamic conditions both in vitro and in vivo.

Methods and Results—

Attachment of human endothelial cells to recombinant α2(VIII) collagen was assessed in vitro under static and shear conditions of up to 100 dyne/cm2. α2(VIII) collagen supported endothelial cell attachment in a dose-dependent manner, with an 18-fold higher affinity for endothelial cells compared with fibronectin. Cell attachment was significantly inhibited by function-blocking anti-α2 (56%) and -β1 (98%) integrin antibodies but was not RGD dependent. Under flow, endothelial cells were retained at significantly higher levels on α2(VIII) collagen (53% and 51%) than either fibronectin (23% and 16%) or glass substrata (7% and 1%) at shear rates of 30 and 60 dyne/cm2, respectively. In vivo studies, using endothelialized polyurethane grafts, demonstrated significantly higher cell retention rates to α2(VIII) collagen-coated than to fibronectin-coated prostheses in the midgraft area (P<0.05) after 24 hours’ implantation in the caprine carotid artery.

Conclusions—

These studies demonstrate that α2(VIII) collagen has the potential to improve both initial cell attachment and retention of endothelial cells on vascular grafts in vivo, which opens new avenues of research into the development of single-stage endothelialized prostheses and the next generation of tissue-engineered vascular grafts.

Related Topics

    loading  Loading Related Articles